Leonid Mikhailovich Brodsky, MD | |
11 Hospital Dr, Machias, ME 04654-3325 | |
(207) 255-0460 | |
(207) 255-0289 |
Full Name | Leonid Mikhailovich Brodsky |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 11 Hospital Dr, Machias, Maine |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1982658423 | NPI | - | NPPES |
050091003 | Other | ME | RAILROAD MEDICARE |
044334 | Other | ME | ANTHEM OF MAINE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | 016091 (Maine) | Primary |
Mailing Address | Practice Location Address |
---|---|
Leonid Mikhailovich Brodsky, MD 11 Hospital Dr, Machias, ME 04654-3325 Ph: (207) 255-0460 | Leonid Mikhailovich Brodsky, MD 11 Hospital Dr, Machias, ME 04654-3325 Ph: (207) 255-0460 |
News Archive
The genetic abnormality that drives the bone cancer Ewing sarcoma operates through two distinct processes - both activating genes that stimulate tumor growth and suppressing those that should keep cancer from developing. These findings by Massachusetts General Hospital investigators, published in the November issue of Cancer Cell, may lead to new therapies targeting these aberrant mechanisms.
Par Pharmaceutical Companies, Inc. (NYSE: PRX) today announced that it has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for the 100mg and 200mg strengths of tramadol ER.
Some California insurers have decided to resume offering children's individual health insurance policies — a step that reverses decisions made last fall to exit this market. Meanwhile, The Wall Street Journal reports that, as a result of requirements in the new health law, some health plans are opting to cut mental health benefits.
A study led by a Johns Hopkins neuroscientist and published in the May 10 issue of the journal Neuron suggests a potential new therapeutic approach for improving memory and interrupting disease progression in patients with a form of cognitive impairment that often leads to full-blown Alzheimer's disease.
In a move that highlights the strength of public-private collaboration in tackling international health challenges, the Maryland-based company Sanaria Inc., with support from the PATH Malaria Vaccine Initiative (MVI), has initiated a Phase 1 clinical trial - the first tests in adult volunteers - of its unique malaria vaccine candidate. Unlike other malaria vaccine candidates, Sanaria's approach deploys a weakened form of the whole malaria parasite harvested from irradiated mosquitoes instead of small portions of the parasite.
› Verified 3 days ago
Rita Fouad Ten, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 229 Main St, Suite 1, Machias, ME 04654 Phone: 207-255-6831 Fax: 207-255-6832 |